Supplier Experience Live 2024 8th October Amsterdam, Official DPW Side Event.

Register Here

The key to building better resilience in pharmaceutical supply chains

Supply Chain Quarterly

By Costas Xyloyiannis, CEO of HICX

While inflation and economic pressures are forcing pharmaceutical brands to watch their pennies, they will do well to not tackle cost efficiency as a solo issue. Brands will also need to focus on resilience in various areas of their incredibly complex supply chain. Chief among these concerns is compliance as stringent regulations must be followed. 

So, can brands manage resilience factors, such as costs and compliance, holistically? 

Both factors have unique requirements, such as finding ways to cut costs or to stop risky activities. However, each factor stems from a common cause: murky supply chains. By fixing poor-quality supplier data, therefore, the pharmaceutical sector can be significantly more resilient at the same time as cutting costs.

Posted in

Share this post